?保费翻倍时刻迫近之际 特朗普施压健康险巨头们下调价格

Core Viewpoint - President Trump is pressuring major health insurance companies to lower costs for consumers facing premium increases after the expiration of Obamacare subsidies, aiming to gain support from middle and low-income voters ahead of the 2026 midterm elections [2][3]. Group 1: Industry Response - Major health insurance companies, including UnitedHealth Group, Cigna, and Humana, saw their stock prices decline after Trump's comments, despite a general rise in the stock market [3]. - The industry organization AHIP stated that premiums reflect the rising costs of medical care and that insurance companies are doing their best to protect Americans from these increasing costs [3]. Group 2: Legislative Context - Over 20 million Americans are projected to see their health insurance premiums double by 2026, which could significantly impact middle and low-income voters already struggling with living costs [4]. - Congress has limited time to address the premium issue before the open enrollment period ends on January 15, with Democrats focusing on the rising costs as a key voter concern [4]. Group 3: Cost Control Measures - Trump prefers a plan that provides direct subsidies for purchasing insurance but is exploring cost-reduction agreements with the industry to mitigate premium increases [3]. - The administration's public pressure on the insurance sector may create uncertainty regarding future profit margins and rate paths, negatively impacting short-term valuations for the sector [4]. Group 4: Pharmaceutical Agreements - Trump announced agreements with nine pharmaceutical companies to lower drug prices for low-income and disabled individuals, which includes selling discounted drugs directly to consumers and aligning U.S. drug prices with those in overseas markets [5][6]. - This initiative is touted as a significant victory in reducing patient costs in the healthcare industry, with expectations of rapid declines in drug prices [6].